AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8967668
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (10 micrograms/kg of body weight) for 18 months
Trial: 30306325
Drug: Oral piroxicam
RxNorm normalized name: Piroxicam
DrugBank: Piroxicam (DB00554)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral piroxicam fast-dissolving tablets
Trial: 25773712
Drug: Lixisenatide 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lixisenatide 2.5 µg
Trial: 25773712
Drug: Lixisenatide 5
RxNorm normalized name: LIXISENATIDE 50/100MCG/MLX3ML START KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lixisenatide 5 µg
Trial: 25773712
Drug: Lixisenatide 10
RxNorm normalized name: LIXISENATIDE 100MCG/ML INJ,SOLN,PEN,3ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lixisenatide 10 µg
Trial: 25773712
Drug: Lixisenatide (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lixisenatide (all doses)
Trial: 25773712
Drug: Lixisenatide (≥5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lixisenatide (≥5 µg)
Trial: 19610055
Drug: Carvedilol 12.5
RxNorm normalized name: carvedilol 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol 12.5 mg once daily
Trial: 1656740
Drug: Azithromycin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (500 mg on day 1, followed by 250 mg on days 2-5)
Trial: 7047863
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone (Deltasone)
Trial: 7047863
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone (Delta‐cortef)
Trial: 7047863
Drug: Intravenous prednisolone
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous prednisolone (Hydeltrasol)
Trial: 7047863
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone and oral prednisolone
Trial: 30447165
Drug: Conventional oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional oral hygiene care programme (COHCP): manual toothbrushing with oral hygiene instruction (OHI)
Trial: 30447165
Drug: Advanced oral
RxNorm normalized name: Imodium Advanced Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Advanced oral hygiene care programme (AOHCP): powered toothbrushing, mouthrinsing with chlorhexidine and OHI
Trial: 24285844
Drug: gD-2 HSV
RxNorm normalized name: Gd-HPDO3A
DrugBank: Gadoteridol (DB00597)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: gD-2 HSV vaccine adjuvanted with ASO4
Trial: 22349765
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (5 g/d for 12 weeks)
Trial: 20814825
Drug: Cysteamine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cysteamine treatment
Trial: 16125534
Drug: No-drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No-drug
Trial: 10573633
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses of rocuronium (400, 600, 800 micrograms/kg)
Trial: 10573633
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses of rocuronium
Trial: 8589028
Drug: Topotecan, administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topotecan, administered at 1.5 mg/m2/day IV x 5 days every 3 weeks
Trial: 27370359
Drug: Adjuvant hormonal
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adjuvant hormonal treatment with a long-acting GnRH agonist for 3 months (Group A)
Trial: 22739669
Drug: Acidulated phosphate
RxNorm normalized name: Acidulated Phosphate Fluoride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acidulated phosphate fluoride gel (APF gel, 1.23% F) for 4 min
Trial: 22739669
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Er,Cr:YSGG laser and APF gel
Trial: 15060257
Drug: Oral creatine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral creatine supplementation (CS) 200 mg/kg per day
Trial: 9758317
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g every 12 hours
Trial: 9758317
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g continuous infusion over 24 hours
Trial: 9758317
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g continuous infusion over 24 hours
Trial: 9758317
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g continuous infusion plus gentamicin 2 mg/kg
Trial: 28746232
Drug: Topical thiocolchicoside
RxNorm normalized name: thiocolchicoside
DrugBank: Thiocolchicoside (DB11582)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical thiocolchicoside (TCC 0.25%) foam 3 times daily
Trial: 28746232
Drug: No topical
RxNorm normalized name: Altreno Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No topical thiocolchicoside (No-TCC)
Trial: 25894106
Drug: Neurofeedback (NFB)
RxNorm normalized name: NFBA
DrugBank: Flutamide (DB00499)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Neurofeedback (NFB) plus pharmacotherapy
Trial: 23265945
Drug: Four rounds
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four rounds of oral visual inspection by trained health workers at 3-year intervals
Trial: 18320411
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral therapy (CBT) during either one session (3 h) or five sessions (1 h each)
Trial: 9010122
Drug: Desipramine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desipramine treatment (N = 6)
Trial: 30798568
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with supplemental treatment
Trial: 7981429
Drug: MK-679 75
RxNorm normalized name: vitamin MK 7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-679 75 mg
Trial: 7981429
Drug: MK-679 250
RxNorm normalized name: vitamin MK 7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-679 250 mg
Trial: 7981429
Drug: MK-679 250
RxNorm normalized name: vitamin MK 7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-679 250 mg (oral) + 14C-MK-679 1 mg (IV)
Trial: 2595746
Drug: Phenobarbital (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenobarbital (200 mg)
Trial: 29230635
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) substitution
Trial: 27647263
Drug: Selenium supplementation
RxNorm normalized name: Selenium supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium supplementation (200 µg/d Se as Se yeast)
Trial: 25017487
Drug: Everolimus with
RxNorm normalized name: Everolimus
DrugBank: Everolimus (DB01590)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Everolimus with very low tacrolimus exposure (1.5-3 ng/mL)
Trial: 25017487
Drug: Everolimus with
RxNorm normalized name: Everolimus
DrugBank: Everolimus (DB01590)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Everolimus with low tacrolimus exposure (4-7 ng/mL)
Trial: 18984650
Drug: Montelukast 4
RxNorm normalized name: montelukast 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast 4 mg sachets, daily from hospital admission until discharge
Trial: 18984650
Drug: Placebo, daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, daily from hospital admission until discharge
Trial: 18984650
Drug: Montelukast 4
RxNorm normalized name: montelukast 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast 4 mg sachets
Trial: 12842372
Drug: 7-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine
Trial: 12842372
Drug: Hepatitis A
RxNorm normalized name: HEPATITIS A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis A or B vaccines
Trial: 8838484
Drug: Desogestrel-containing preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desogestrel-containing preparation
Trial: 1299421
Drug: alpha‐2a Interferon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alpha‐2a Interferon (IFN) (100,000 I.U. in 1 ml)
Trial: 7796587
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive containing 30 mcg ethinylestradiol and 150 mcg desogestrel
Trial: 7796587
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive containing 30 mcg ethinylestradiol and 75 mcg gestodene
Trial: 2442560
Drug: Lisinopril 5
RxNorm normalized name: lisinopril 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril 5 mg daily (with option to increase to 10 or 20 mg)
Trial: 23385792
Drug: Lutein supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lutein supplementation (10 mg Ester daily)
Trial: 23385792
Drug: Lutein supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lutein supplementation (10 mg Ester daily) in subgroup (n = 19)
Trial: 19077388
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg oral pyridoxine thrice daily
Trial: 16148965
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group received the 2000 version of the Medicare & You handbook; control group received no Medicare-related information.
Trial: 8359565
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of Sandostatin (SMS)
Trial: 2444797
Drug: Felodipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine (10 mg twice daily for 8 weeks)
Trial: 11456286
Drug: Gliclazide 160
RxNorm normalized name: gliclazide
DrugBank: Gliclazide (DB01120)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gliclazide 160 mg
Trial: 30208070
Drug: Symptom-guided treatment
RxNorm normalized name: Pamprin Multi-Symptom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symptom-guided treatment (Control)
Trial: 24797121
Drug: Low-dose opioid
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose opioid regimen (remifentanil effect-site concentration half of propofol)
Trial: 24797121
Drug: High-dose opioid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose opioid regimen (remifentanil effect-site concentration double that of propofol)
Trial: 17634269
Drug: Medox (anthocyanin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medox (anthocyanin supplementation, 300 mg/d for 3 weeks)
Trial: 7665416
Drug: Added fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Added fat and protein (FP) diet (C diet + 1.6 g.kg‐1.day‐1 fat + 1.2 g.kg‐1.day‐1 protein)
Trial: 7665416
Drug: Control (C)
RxNorm normalized name: Afeditab CR
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control (C) diet (high glycemic index CHO foods; CHO = 7 g.kg‐1.day‐1)
Trial: 7665416
Drug: Matched-energy diet
RxNorm normalized name: Senergy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matched-energy diet (C diet + 4.8 g.kg‐1.day‐1 additional CHO)
Trial: 25203688
Drug: 39 g·hr(‐1)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 39 g·hr(‐1) carbohydrate (CHO)
Trial: 25203688
Drug: 64 g·hr(‐1)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 64 g·hr(‐1) carbohydrate (CHO)
Trial: 25203688
Drug: 20 g·hr(‐1)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g·hr(‐1) carbohydrate (CHO)
Trial: 25203688
Drug: 0 g·hr(‐1)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g·hr(‐1) control (water)
Trial: 12590356
Drug: Risperidone 2-6
RxNorm normalized name: risperidone 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone 2-6 mg/day
Trial: 12590356
Drug: Olanzapine 5-20
RxNorm normalized name: olanzapine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine 5-20 mg/day
Trial: 10565798
Drug: Amitriptyline (50-250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (50-250 mg/day, mean 138.1 mg/day)
Trial: 6136695
Drug: Combination cytotoxic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination cytotoxic chemotherapy (intravenous cyclophosphamide, methotrexate, and fluorouracil)
Trial: 6136695
Drug: No chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No chemotherapy or conventionally timed chemotherapy
Trial: 31493951
Drug: AdtFMD vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AdtFMD vaccine (commercial vaccine vector expressing capsid proteins of FMDV strain A24 Cruzeiro)
Trial: 27481104
Drug: Personalized exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Personalized exercise prescription (intensity that 'feels good' to the individual for 8 weeks during daily Physical Education)
Trial: 27481104
Drug: Moderate-intensity exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate-intensity exercise prescription (target heart rate range 60-80% of HR max for 8 weeks during daily Physical Education)
Trial: 22495590
Drug: Sympathetic inhibition
RxNorm normalized name: Bos taurus sympathetic nerve preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sympathetic inhibition via clonidine (48 h transdermal administration) during hypoxia
Trial: 12452301
Drug: Enoxaparin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin (1 mg/kg twice daily by SC injection)
Trial: 12452301
Drug: Dalteparin (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalteparin (120 IU/kg twice daily by SC injection)
Trial: 9607384
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg tasosartan
Trial: 9607384
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg tasosartan
Trial: 9607384
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg tasosartan
Trial: 9607384
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg tasosartan
Trial: 8169569
Drug: Choice between
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Choice between previously sampled doses (0.0%, 2.0%, and 3.5%)
Trial: 31497988
Drug: Oral alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral alcohol administration (exact dosage not specified)
Trial: 31497988
Drug: Oral alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral alcohol administration
Trial: 19648776
Drug: 5% dexpanthenol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% dexpanthenol ointment
Trial: 19648776
Drug: Placebo ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo ointment (vehicle without dexpanthenol)
Trial: 11379804
Drug: Intranasal IL-6
RxNorm normalized name: IL-6
DrugBank: Human interleukin-6 (DB15060)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal IL-6 (0, 0.01, 0.1, and 1 microg/mL)
Trial: 9224439
Drug: Behavioral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral treatment emphasizing patient pleasant events
Trial: 9224439
Drug: Behavioral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral treatment emphasizing caregiver problem solving
Trial: 3611398
Drug: Lorazepam (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam (4 mg orally)
Trial: 2667015
Drug: Desmethylimipramine (DMI)
RxNorm normalized name: Desmethylimipramine
DrugBank: Desipramine (DB01151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desmethylimipramine (DMI) 50 mg oral test dose
Trial: 31520258
Drug: No acupuncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No acupuncture therapy (Control)
Trial: 21702877
Drug: Infant massage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infant massage intervention (daily for 10 weeks)
Trial: 9386211
Drug: Continuous combined
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous combined HRT with Kliogest (daily tablet for 9 months)
Trial: 7952793
Drug: Inhaled salmeterol
RxNorm normalized name: salmeterol Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled salmeterol 12.5, 50 and 100 micrograms
Trial: 7952793
Drug: Inhaled salmeterol
RxNorm normalized name: salmeterol Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled salmeterol 50 and 100 micrograms
Trial: 7952793
Drug: Inhaled salmeterol
RxNorm normalized name: salmeterol Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled salmeterol and salbutamol
Trial: 2438095
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of salbutamol and theophylline
Trial: 26397235
Drug: Lidocaine infusion
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine infusion (1.5 mg/kg IV bolus followed by 2 mg/kg/h infusion until end of surgery)
Trial: 24534082
Drug: Supervised exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supervised exercise program (12-week, thrice weekly)
Trial: 22948049
Drug: Stanford V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Stanford V chemotherapy
Trial: 20063935
Drug: Cognitive function
RxNorm normalized name: plasma protein fraction Injection [Plasmanate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive function assessment (not specified dosage or duration)
Trial: 15694083
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol 25 microg every 3 days for a maximum of three doses
Trial: 15694083
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol 50 microg every 3 days for a maximum of three doses
Trial: 12798694
Drug: RT (Radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RT (Radiation Therapy)
Trial: 12798694
Drug: RT +
RxNorm normalized name: CVS Yogurt + Fiber Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RT + HYST (Radiation Therapy with Extrafascial Hysterectomy)
Trial: 10365928
Drug: Topical azelaic
RxNorm normalized name: azelaic acid Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical azelaic acid 20% cream
Trial: 10365928
Drug: Topical metronidazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical metronidazole 0.75% cream
Trial: 6756934
Drug: Piretanide 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piretanide 1.0 mg
Trial: 6756934
Drug: Frusemide 6.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frusemide 6.25 mg
Trial: 24743706
Drug: Experimental therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental therapies (specific therapies not detailed)
Trial: 24743706
Drug: FOLFIRI chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FOLFIRI chemotherapy (common control arm)
Trial: 23890766
Drug: Asthma Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Asthma Therapy Assessment Questionnaire (ATAQ)
Trial: 17975232
Drug: PCEA with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCEA with meperidine (2 mg/mL) + adrenaline (2 µg/mL)
Trial: 17975232
Drug: PCEA with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCEA with meperidine (2 mg/mL) alone
Trial: 15125570
Drug: Citric acid
RxNorm normalized name: Citric Acid
DrugBank: Citric acid (DB04272)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Citric acid in the tablet matrix (10-15%)
Trial: 15125570
Drug: Ibuprofen (model
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (model drug)
Trial: 7637825
Drug: Radiotherapy (RT)
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Radiotherapy (RT) and chemotherapy (ChT) containing cisplatinum and 5-fluorouracil (5-FU)
Trial: 880567
Drug: Methotrexate high
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate high dose (0.06 mg/kg/dose)
Trial: 880567
Drug: Methotrexate low
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate low dose (0.2 mg/kg/dose)
Trial: 880567
Drug: Methotrexate high
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate high dose and low dose